Articles featuring the patient perspective on adult stem cells

Autologous Cell Therapies Do Not Represent a Public Health Risk and Should Not Be Regulated Like Drugs
CellR4 2013; 1 (3): e592 Mike Phelan, The Official Journal of The Cure Alliance,

4 part series on evolving role of stem cell therapy in American medicine.
♦ Stem cells spark controversy
10/23/2013 Chelsea Henderson, Lamar University Press

♦ FDA wary of ‘biological drugs’
10/30/2013 Chelsea Henderson, Lamar University Press

♦ Patients seek to reclaim stem cells
11/6/2013 Chelsea Henderson, Lamar University Press

♦ Handley leaves US for stem cells
11/13/2013 Chelsea Henderson, Lamar University Press

Lack of Proven Efficacy: A Legitimate Reason to Deny Access to Cellular Therapies or a Barrier to Innovative Trials and the Development of Cures
CellR4 2013; 1 (2): e403 SammyJo Wilkinson, The Official Journal of The Cure Alliance

Are Excessive Regulations Prohibiting Doctors from Trying to Cure Patients?
CellR4 2013; 1 (2): e401 Claire Hooper, The Official Journal of The Cure Alliance

Why Clinics that Use Adult Stem Cells Administered by Physicians Represent a Threat to Industry
CellR4 2013; 1 (2): e395 Barb Hanson, The Official Journal of The Cure Alliance

When “No Option” Is Not an Acceptable Option
CellR4 2013; 1 (2): e390 Jennifer Ziegler, The Official Journal of The Cure Alliance

Whose stem cells are they anyway?
08/13/2013 Peter Aldhous, New Scientist

Stem cells being used to cure back pain
06/13/2013 Peter Ostrow, WIVB.com 4 News

New Stem Cell Book Highlights The Patient Perspective
04/30/2013 John Farrell, Forbes Contributor

Stem cells used to repair knees, joint damage
02/27/2013 Jean Enersen, KING 5 News

One Man’s Reluctant Tour For Adult Stem Cells
02/21/2013 John Farrell, Forbes Contributor

FDA Challenges Stem Cell Companies As Patients Run Out Of Time
02/02/2013 NPR All Things Considered

Stem Cell Showdown: Celltex vs. the FDA
01/03/2013 Susan Berfield, Business Week

---